Evidence map›Paper›PMID 41608218›Full record

ReviewJuntendo medical journal2025

Diagnosis and Management of Heat-related Illness: Clinical and Molecular Perspectives.

Julie Helms, Kenta Kondo, Kunishiko Nagakari, Toshiaki Iba

Abstract readReview
In one paragraph

Review in Juntendo medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Julie Helms
Kenta Kondo
Kunishiko Nagakari
Toshiaki Iba

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heat-related illness (HRI) represents a growing public health challenge in the context of global warming. Ranging from mild symptoms such as heat cramps to life-threatening heatstroke, HRI requires prompt recognition and appropriate management to reduce morbidity and mortality. The diagnosis of HRI is primarily based on clinical symptoms but is supported by laboratory evaluation, especially in severe cases. Heatstroke, the most critical form, is defined by core body temperature ≥ 40°C and central nervous system dysfunction. In addition to conventional laboratory markers, recent advances in molecular biology have identified several biomarkers, such as heat shock proteins, HMGB1 (High Mobility Group Box 1), and mitochondrial DNA, which may improve early and accurate detection and prognostication. This review summarizes the diagnostic approach to HRI, highlighting key clinical findings, laboratory assessments, and emerging molecular markers.

Indexed as

cell deathdamage-associated molecular patternsheat strokeleukocytemitochondriaorgan dysfunction

Identifiers

PMID41608218
PMCPMC12835440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.